Entire family of Defibtech AEDs Now Available to U.S. Customers

The Defibtech Lifeline PRO and Lifeline ECG automated external defibrillators (AEDs) have been cleared for sale in the U.S. market by the Food and Drug Administration.

AEDs are designed to revive victims of sudden cardiac arrest, which strikes about 380,000 Americans each year and is the leading cause of death in the U.S.

“With the addition of the Lifeline PRO and ECG AEDs, the entire family of Lifeline AEDs is now available in the U.S.,” Defibtech CEO Glenn W. Laub said. “There are excellent options for every customer, no matter the budget or the need. With sudden cardiac arrest such a common and foreseeable occurrence, all workplaces and public places should take the reasonable precaution of having at least one AED onsite.”

Both the Lifeline PRO and ECG AEDs are designed for professional responders. The Lifeline PRO provides full manual control over shock energy and delivery as an option. When the Lifeline PRO is operated in manual mode, an ECG appears on the color video display, and the rescuer can select the energy level and decide when to initiate charge and shock.

Operating in semi-automatic or “AED” mode, both the Lifeline PRO and ECG AEDs can display either an ECG or video instructions for the rescuer. In this mode, the AED determines whether or not a shock is warranted through field-proven arrhythmia detection technology. Both models’ video and audio provide guidance on where to place the defibrillating pads and give step-by-step lifesaving instructions. For example, when the audio says, “Place pads on patient’s chest,” the video shows exactly where to place the pads.

Both the Lifeline PRO and ECG AEDs continue Defibtech’s tradition of ease-of-maintenance with extensive configuration and information menus presented on the color video display. When CPR protocols change, users can update the audio and video instructions in the field by installing a software upgrade.

Both the Lifeline PRO and ECG AEDs are also distinguished by ruggedness and durability, award-winning ergonomic design, and biphasic technology, a clinically proven waveform and algorithm to deliver shocks and save lives.